Management of depression in the presence of pain symptoms.
Mohr
Pavel
P
Prague Psychiatric Center, Czech Republic. mohr@pcp.lf3.cuni.cz
Bitter
István
I
Svestka
Jaromír
J
Seifritz
Erich
E
Karamustafalioglu
Oguz
O
Koponen
Hannu
H
Sartorius
Norman
N
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D015897:Comorbidity; D003511:Cyclohexanols / Q000009:adverse effects / Q000627:therapeutic use*; D003521:Cyclopropanes / Q000009:adverse effects / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D004359:Drug Therapy, Combination; D000068736:Duloxetine Hydrochloride; D005356:Fibromyalgia / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D006801:Humans; D000078764:Milnacipran; D019222:Mind-Body Relations, Metaphysical / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000378:metabolism; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D011613:Psychotherapy; D012701:Serotonin / Q000378:metabolism; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
D000928:Antidepressive Agents; D003511:Cyclohexanols; D003521:Cyclopropanes; D013876:Thiophenes; D012701:Serotonin; D000069470:Venlafaxine Hydrochloride; D000068736:Duloxetine Hydrochloride; D000078764:Milnacipran; D009638:Norepinephrine